Le Lézard
Classified in: Health, Covid-19 virus
Subject: CSR

Quest Diagnostics Releases Annual Environmental, Social & Governance Report


SECAUCUS, N.J., Aug. 12, 2020 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, today released its Annual Environmental, Social & Governance Report for 2019.

The report features business updates from 2019 and early 2020 as well as programs and partnerships that demonstrate the company's commitment to positively impacting its patients, clients, employees and the communities in which it operates.

"We are proud of what we have accomplished, and our impact on empowering better health," said Cecilia McKenney, Senior Vice President, Chief Human Resources Officer for Quest Diagnostics. "The report is brought to life every day by our 47,000 employees who help us promote a healthier world, create an inspiring workplace, and build value for our company."

The report features key achievements from 2019 and spotlights the company's role in responding to the COVID-19 pandemic. These include:      

Click here to view the report on the Quest Diagnostics corporate website. 

About Quest Diagnostics

Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 47,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. www.QuestDiagnostics.com.

SOURCE Quest Diagnostics


These press releases may also interest you

at 06:50
U.S. FDA Approves Pfizer's BEQVEZtm (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B
Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved BEQVEZtm (fidanacogene elaparvovec-dzkt) for the treatment of adults with moderate to severe hemophilia B who currently use factor IX (FIX) prophylaxis...

at 06:15
Carter's, Inc. Reports First Quarter Fiscal 2024 Results
Carter's, Inc. , the largest branded marketer in North America of apparel exclusively for babies and young children, today reported its first quarter fiscal 2024 results. "We exceeded our sales and earnings objectives in the first quarter," said...

at 06:01
Aon Reports First Quarter 2024 Results
First Quarter Key Metrics Total revenue increased 5% to $4.1 billion, including organic revenue growth of 5%Operating margin decreased 210 basis points to 36.0%, and operating margin, adjusted for certain items, increased 100 basis points to 39.7%EPS...

at 06:00
Ball Reports First Quarter 2024 Results
Highlights First quarter U.S. GAAP total diluted earnings per share of $11.61, inclusive of gain on aerospace sale, vs. 56 cents in 2023First quarter comparable diluted earnings per share of 68 cents vs. 69 cents in 2023Global beverage can shipments...

at 05:45
QuidelOrtho Corporation f/k/a Quidel Corporation Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - QDEL
The Gross Law Firm issues the following notice to shareholders of QuidelOrtho Corporation f/k/a Quidel Corporation . Shareholders who...

at 05:45
Class Action Filed Against Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II (KIND) - April 29, 2024 Deadline to Join - Contact The Gross Law Firm
The Gross Law Firm issues the following notice to shareholders of Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II ....

More news about Covid-19 virus...


News published on and distributed by: